Jubilant Pharmova Ltd. NSE: JUBLPHARMA | BSE: 530019

Mid-range Performer

In 2 Starfolio Baskets

Download real time

1037.90 -2.70 (-0.26%)

29.41% Gain from 52W Low

6,389

NSE+BSE Volume

NSE 14 Jan, 2026 9:58 AM (IST)

Jubilant Pharmova Earnings/Conference Calls

Jubilant Pharmova earnings concalls and investor presentations

Search Inside the pdf :

Jubilant Pharmova Ltd.

24 Feb 2025

1037.90

-0.26%

Earnings Call

Jubilant Pharmova Ltd - 530019 - Audio Recording Of Investors / Analysts Meeting

BSE India

Audio Recording of Investors Meet

Jubilant Pharmova Ltd.

09 Feb 2023

1037.90

-0.26%

Earnings Call

Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of earnings conference call for the quarter and nine months ended December 31, 2022

Jubilant Pharmova Ltd.

03 Feb 2023

1037.90

-0.26%

Earnings Call

Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Link of Audio recording of investors conference call

Jubilant Pharmova Ltd.

31 Oct 2022

1037.90

-0.26%

Earnings Call

Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Transcript of Analyst and Investor Conference Call

Jubilant Pharmova Ltd.

22 Oct 2022

1037.90

-0.26%

Earnings Call

Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Link of audio recording

Jubilant Pharmova Ltd.

08 Aug 2022

1037.90

-0.26%

Earnings Call

Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the transcript of Analyst and Investor Conference Call for Unaudited financial results for the quarter ended June 30, 2022 conducted after the meeting of Board of Directors held on Tuesday, August 2, 2022. This is for your information and records.

Jubilant Pharmova Ltd.

02 Aug 2022

1037.90

-0.26%

Results Earnings Call for Q1FY23 of Jubilant Pharmova

Conference Call with Jubilant Pharmova Management and Analysts on Q1FY23 Performance and Outlook. Listen to the full earnings transcript.

Jubilant Pharmova Ltd.

02 Aug 2022

1037.90

-0.26%

Earnings Call

Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

we wish to inform that audio recording of Analyst and Investor Conference Call for Unaudited financial results for the quarter ended June 30, 2022 held on Tuesday, August 2, 2022, has been uploaded on the Company''s website and same is given in the attached letter.

Jubilant Pharmova Ltd.

02 Jun 2022

1037.90

-0.26%

Earnings Call

Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of the earnings conference call for the quarter and year ended March 31, 2022

Jubilant Pharmova Ltd.

28 May 2022

1037.90

-0.26%

Earnings Call for Q4FY22 of Jubilant Pharmova

Conference Call with Jubilant Pharmova Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.

Is Jubilant Life Sciences Ltd. worth buying?

384 Votes:

Buy 80.47%

Sell 11.2%

Hold 8.33%

RESEARCH REPORTS

Buy SEE REPORTS >

Hold SEE REPORTS >